Amgen seeks FDA approval for monthly dosing option for Repatha
 

Amgen seeks FDA approval for monthly dosing option for Repatha
Sept 11 (Reuters) - Amgen Inc said it had asked the U.S. Food and Drug Administration to approve a monthly single-dosing option for its recently approved cholesterol drug, Repatha.


http://rc.feedsportal.com/r/23838566...19/rc/1/rc.img

http://rc.feedsportal.com/r/23838566...19/rc/2/rc.img

http://rc.feedsportal.com/r/23838566...19/rc/3/rc.img

http://da.feedsportal.com/r/23838566...9/sc/19/a2.img
http://adchoice.feedsportal.com/r/23.../sc/19/ach.imghttp://pi.feedsportal.com/r/23838566.../sc/19/a2t.imghttp://pi2.feedsportal.com/r/2383856...sc/19/a2t2.imghttp://i2.wp.com/reuters.us.feedspor...f?resize=1%2C1http://feeds.feedburner.com/~ff/reut...?d=yIl2AUoC8zA http://feeds.feedburner.com/~ff/reut...HE:V_sGLiPBpWU http://feeds.feedburner.com/~ff/reut...HE:F7zBnMyn0Lo
http://feeds.feedburner.com/~r/reute...~4/-EfBOjk3jeY